Therapeutic Effects of a New Upper Limb Robot Assisted Therapy Device for Persons After Stroke (ARTHE)

December 10, 2012 updated by: Lore Van de Perre, Thomas More Kempen

Active Smart Wearable Orthosis Using Painted EMG Electrodes for Home Based Therapy With Augmentative Feedback

The purpose of this pilot study is to investigate the clinical effects of a new upper limb robot assisted therapy device that is linked to a virtual therapy environment in patients with stroke.

Study Overview

Status

Unknown

Conditions

Detailed Description

The number of physically weak individuals is increasing, resulting in a higher burden on health care and health care workers. The use of robot assisted therapy (RAT) might partly solve this problem. Rehabilitation progress highly depends on training intensity and training duration, favouring the use of RAT.

In this pilot study, the clinical effects of using a new upper arm RAT device for upper arm rehabilitation in patients with stroke is investigated. Myo-electrical signals will serve as input for the device, assisting the user in flexion and extension of the elbow. The device is coupled to a virtual environments, creating a stimulating therapy environment.

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Antwepen
      • Geel, Antwepen, Belgium, 2440
        • Thomas More Kempen
        • Contact:
        • Contact:
        • Principal Investigator:
          • Lore Van de Perre, MSc
        • Sub-Investigator:
          • Roy Sevit, MSc
        • Sub-Investigator:
          • Koen Janssens, MSc
        • Sub-Investigator:
          • Peter Karsmakers, PhD
        • Sub-Investigator:
          • Louis Peeraer, Prof.PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with stroke, more than three months post onset
  • No or moderate spasticity in the upper limb (maximum score of 3 on Modified Ashworth Scale)
  • Observable voluntary muscle activity in biceps and triceps muscle of the affected upper limb (minimal score of 1 on the Medical research council score)
  • Able to sit on a chair with adequate trunk stability
  • Able to follow verbal instructions
  • Able to communicate verbal information to the researchers

Exclusion Criteria:

  • Patients who are medically unstable
  • Cognitive disorders impeding the intervention
  • Visual disorders impeding the intervention
  • Subluxation of the shoulder joint
  • Pusher syndrome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training with the device
Training with new upper limb robot assisted therapy device
During 8 weeks, 3 times a week, 1 hour therapy sessions with the device
Other Names:
  • exoskeleton
  • active orthosis
No Intervention: Control group
The control group is treated with conventional therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer test upper limb section
Time Frame: Change from baseline Fugl-Meyer test upper limb section at 8 weeks and 12 weeks
Stroke specific, performance based impairment index. Applied to determine disease severity and describe motor recovery.
Change from baseline Fugl-Meyer test upper limb section at 8 weeks and 12 weeks
Medical research council score
Time Frame: Change from baseline Medical research council score at 8 weeks and 12 weeks
Muscle strength assessment
Change from baseline Medical research council score at 8 weeks and 12 weeks
Active range of motion of the elbow joint
Time Frame: Change from baseline active range of motion of the elbow joint at 8 weeks and 12 weeks
The maximum range of motion to flexion and extension of the elbow joint that the person can achieve independently
Change from baseline active range of motion of the elbow joint at 8 weeks and 12 weeks
Passive range of motion of the elbow joint
Time Frame: Change from baseline passive range of motion of the elbow joint at 8 weeks and 12 weeks
The maximum range of motion to flexion and extension of the elbow joint of the test person that can be achieved by the assessor.
Change from baseline passive range of motion of the elbow joint at 8 weeks and 12 weeks
Modified Ashworth Scale
Time Frame: Change from baseline Modified Ashworth Scale at 8 weeks and 12 weeks
Spasticity measurement
Change from baseline Modified Ashworth Scale at 8 weeks and 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ABILHAND questionnaire
Time Frame: Change from baseline ABILHAND questionnaire score at 8 weeks and 12 weeks
Questionnaire-based assessment of manual ability
Change from baseline ABILHAND questionnaire score at 8 weeks and 12 weeks
Functional independence measure
Time Frame: Change from baseline Functional independence measure score at 8 weeks and 12 weeks
Assessment of physical and cognitive disability, focusing on the burden of care.
Change from baseline Functional independence measure score at 8 weeks and 12 weeks
Stroke impact scale
Time Frame: Change from baseline Stroke impact scale score at 8 weeks and 12 weeks
Questionnaire evaluating how stroke has impacted the person's health and life.
Change from baseline Stroke impact scale score at 8 weeks and 12 weeks
Intrinsic motivation inventory
Time Frame: Change from baseline Intrinsic motivation inventory score at 8 weeks and 12 weeks
Multidimensional measurement device intended to assess participants' subjective experience related to a target activity in laboratory experiments.
Change from baseline Intrinsic motivation inventory score at 8 weeks and 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lore Van de Perre, MSc, Thomas More Kempen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2013

Primary Completion (Anticipated)

July 1, 2014

Study Completion (Anticipated)

September 1, 2014

Study Registration Dates

First Submitted

October 30, 2012

First Submitted That Met QC Criteria

November 5, 2012

First Posted (Estimate)

November 7, 2012

Study Record Updates

Last Update Posted (Estimate)

December 11, 2012

Last Update Submitted That Met QC Criteria

December 10, 2012

Last Verified

December 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Training with new upper limb robot assisted therapy device

3
Subscribe